Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

The proteome microenvironment determines the protective effect of preconditioning in cisplatin-induced acute kidney injury.

Späth MR, Bartram MP, Palacio-Escat N, Hoyer KJR, Debes C, Demir F, Schroeter CB, Mandel AM, Grundmann F, Ciarimboli G, Beyer A, Kizhakkedathu JN, Brodesser S, Göbel H, Becker JU, Benzing T, Schermer B, Höhne M, Burst V, Saez-Rodriguez J, Huesgen PF, Müller RU, Rinschen MM.

Kidney Int. 2019 Feb;95(2):333-349. doi: 10.1016/j.kint.2018.08.037. Epub 2018 Dec 3.

PMID:
30522767
2.

Short-term preconditioning enhances the therapeutic potential of adipose-derived stromal/stem cell-conditioned medium in cisplatin-induced acute kidney injury.

Overath JM, Gauer S, Obermüller N, Schubert R, Schäfer R, Geiger H, Baer PC.

Exp Cell Res. 2016 Mar 15;342(2):175-83. doi: 10.1016/j.yexcr.2016.03.002. Epub 2016 Mar 15.

PMID:
26992633
3.

Monitoring treatment of acute kidney injury with damage biomarkers.

Pianta TJ, Succar L, Davidson T, Buckley NA, Endre ZH.

Toxicol Lett. 2017 Feb 15;268:63-70. doi: 10.1016/j.toxlet.2017.01.001. Epub 2017 Jan 5.

PMID:
28065798
4.

CD4 T cell knockout does not protect against kidney injury and worsens cancer.

Ravichandran K, Wang Q, Ozkok A, Jani A, Li H, He Z, Ljubanovic D, Weiser-Evans MC, Nemenoff RA, Edelstein CL.

J Mol Med (Berl). 2016 Apr;94(4):443-55. doi: 10.1007/s00109-015-1366-z. Epub 2015 Dec 1.

PMID:
26620676
5.

Limb ischemic preconditioning protects against contrast-induced acute kidney injury in rats via phosphorylation of GSK-3β.

Liu T, Fang Y, Liu S, Yu X, Zhang H, Liang M, Ding X.

Free Radic Biol Med. 2015 Apr;81:170-82. doi: 10.1016/j.freeradbiomed.2014.10.509. Epub 2014 Oct 31.

PMID:
25451640
6.

Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action.

Liu Z, Gong R.

Am J Kidney Dis. 2015 Nov;66(5):846-56. doi: 10.1053/j.ajkd.2015.06.026. Epub 2015 Aug 10. Review.

7.

Pharmacokinetic changes of cefdinir and cefditoren and its molecular mechanisms in acute kidney injury in rats.

Wang H, Sun P, Wang C, Meng Q, Liu Z, Huo X, Sun H, Ma X, Peng J, Liu K.

J Pharm Pharmacol. 2018 Nov;70(11):1503-1512. doi: 10.1111/jphp.12994. Epub 2018 Jul 25.

PMID:
30047127
8.

The water-soluble triptolide derivative PG490-88 protects against cisplatin-induced acute kidney injury.

Kim HJ, Ravichandran K, Ozkok A, Wang Q, He Z, Jani A, Ljubanovic D, Douglas IS, Edelstein CL.

J Pharmacol Exp Ther. 2014 Jun;349(3):518-25. doi: 10.1124/jpet.114.213769. Epub 2014 Apr 11.

PMID:
24727856
9.

AMP-activated protein kinase regulates autophagic protection against cisplatin-induced tissue injury in the kidney.

Wei L, Chen W, Zou Y, Huang H, Pan B, Jin S, Huang R, Nie S, Kong G.

Genet Mol Res. 2015 Oct 5;14(4):12006-15. doi: 10.4238/2015.October.5.13.

10.

Developing better mouse models to study cisplatin-induced kidney injury.

Sharp CN, Siskind LJ.

Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F835-F841. doi: 10.1152/ajprenal.00285.2017. Epub 2017 Jul 19. Review.

11.

MicroRNA-140-5p attenuated oxidative stress in Cisplatin induced acute kidney injury by activating Nrf2/ARE pathway through a Keap1-independent mechanism.

Liao W, Fu Z, Zou Y, Wen D, Ma H, Zhou F, Chen Y, Zhang M, Zhang W.

Exp Cell Res. 2017 Nov 15;360(2):292-302. doi: 10.1016/j.yexcr.2017.09.019. Epub 2017 Sep 18. Erratum in: Exp Cell Res. 2017 Dec 1;361(1):199.

PMID:
28928081
12.

NF-κB transcriptional inhibition ameliorates cisplatin-induced acute kidney injury (AKI).

Ozkok A, Ravichandran K, Wang Q, Ljubanovic D, Edelstein CL.

Toxicol Lett. 2016 Jan 5;240(1):105-13. doi: 10.1016/j.toxlet.2015.10.028. Epub 2015 Nov 3.

PMID:
26546572
13.

Intra-renal arterial injection of autologous bone marrow mesenchymal stromal cells ameliorates cisplatin-induced acute kidney injury in a rhesus Macaque mulatta monkey model.

Moghadasali R, Azarnia M, Hajinasrollah M, Arghani H, Nassiri SM, Molazem M, Vosough A, Mohitmafi S, Najarasl M, Ajdari Z, Yazdi RS, Bagheri M, Ghanaati H, Rafiei B, Gheisari Y, Baharvand H, Aghdami N.

Cytotherapy. 2014 Jun;16(6):734-49. doi: 10.1016/j.jcyt.2014.01.004.

PMID:
24801377
14.

Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.

Chen CL, Liao JW, Hu OY, Pao LH.

Arch Toxicol. 2016 Sep;90(9):2249-2260. doi: 10.1007/s00204-015-1607-5. Epub 2015 Oct 5.

PMID:
26438401
15.

Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.

Shinke H, Masuda S, Togashi Y, Ikemi Y, Ozawa A, Sato T, Kim YH, Mishima M, Ichimura T, Bonventre JV, Matsubara K.

Cancer Chemother Pharmacol. 2015 Nov;76(5):989-96. doi: 10.1007/s00280-015-2880-y. Epub 2015 Sep 25.

16.

Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation.

Yang C, Guo Y, Huang TS, Zhao J, Huang XJ, Tang HX, An N, Pan Q, Xu YZ, Liu HF.

Biomed Pharmacother. 2018 Nov;107:1354-1362. doi: 10.1016/j.biopha.2018.08.126. Epub 2018 Aug 30.

PMID:
30257350
17.

Estrogen-related receptor α is essential for maintaining mitochondrial integrity in cisplatin-induced acute kidney injury.

Tsushida K, Tanabe K, Masuda K, Tanimura S, Miyake H, Arata Y, Sugiyama H, Wada J.

Biochem Biophys Res Commun. 2018 Apr 15;498(4):918-924. doi: 10.1016/j.bbrc.2018.03.080. Epub 2018 Mar 16.

PMID:
29545177
18.

Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.

Qi S, Wu D.

Int J Mol Med. 2013 Dec;32(6):1262-72. doi: 10.3892/ijmm.2013.1517. Epub 2013 Oct 8.

19.

Inhibition of PTEN activity aggravates cisplatin-induced acute kidney injury.

Zhou J, Fan Y, Tang S, Wu H, Zhong J, Huang Z, Yang C, Chen H.

Oncotarget. 2017 Sep 8;8(61):103154-103166. doi: 10.18632/oncotarget.20790. eCollection 2017 Nov 28.

20.

Enhanced renoprotective effect of HIF-1α modified human adipose-derived stem cells on cisplatin-induced acute kidney injury in vivo.

Wang WW, Li ZZ, Wang W, Jiang Y, Cheng J, Lu S, Zhang JY.

Sci Rep. 2015 Jun 5;5:10851. doi: 10.1038/srep10851.

Supplemental Content

Support Center